TDOC · Teladoc Health, Inc. · Share Buybacks
5 customers — 33% of revenue (nine months ended September 30, 2026)
“Revenue from the five largest Clients accounted for 33% and 31% of total Integrated Care segment revenue for the nine months ended September 30, 2026 and 2025, respectively.”
5 customers — 31% of revenue (nine months ended September 30, 2025)
“Revenue from the five largest Clients accounted for 33% and 31% of total Integrated Care segment revenue for the nine months ended September 30, 2026 and 2025, respectively.”
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2014-12-31 | $368,000 | 10-K, filed 2017-03-01 |
| 2013-12-31 | $71,000 | 10-K, filed 2016-03-03 |